Global Peripheral Intervention Drug-Eluting Devices Sales Market Report 2021

1 Peripheral Intervention Drug-Eluting Devices Market Overview

• 1.1 Peripheral Intervention Drug-Eluting Devices Product Scope
• 1.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
  • 1.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Plain Old Balloon Angioplasty (POBA)
  • 1.2.3 Percutaneous Transluminal Angioplasty (PTA)
• 1.3 Peripheral Intervention Drug-Eluting Devices Segment by Application
  • 1.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Drug-Eluting Balloons
  • 1.3.3 Drug-Eluting Stents
• 1.4 Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Peripheral Intervention Drug-Eluting Devices Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Peripheral Intervention Drug-Eluting Devices Price Trends (2016-2027)

2 Peripheral Intervention Drug-Eluting Devices Estimates and Forecasts by Region

• 2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2016-2021)
• 2.3 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2016-2027)
  • 2.4.2 Europe Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2016-2027)
  • 2.4.3 China Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2016-2027)
  • 2.4.4 Japan Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2016-2027)
  • 2.4.6 India Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2016-2027)

3 Global Peripheral Intervention Drug-Eluting Devices Competition Landscape by Players

• 3.1 Global Top Peripheral Intervention Drug-Eluting Devices Players by Sales (2016-2021)
• 3.2 Global Top Peripheral Intervention Drug-Eluting Devices Players by Revenue (2016-2021)
• 3.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2020)
• 3.4 Global Peripheral Intervention Drug-Eluting Devices Average Price by Company (2016-2021)
• 3.5 Manufacturers Peripheral Intervention Drug-Eluting Devices Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Peripheral Intervention Drug-Eluting Devices Market Size by Type

• 4.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2016-2021)
• 4.2 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2022-2027)

5 Global Peripheral Intervention Drug-Eluting Devices Market Size by Application

• 5.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2016-2021)
• 5.2 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Application (2022-2027)

6 North America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures

• 6.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Company
  • 6.1.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Company (2016-2021)
  • 6.1.2 North America Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021)
• 6.2 North America Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type
  • 6.2.1 North America Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
• 6.3 North America Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application
  • 6.3.1 North America Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application (2022-2027)

7 Europe Peripheral Intervention Drug-Eluting Devices Market Facts & Figures

• 7.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Company
  • 7.1.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Company (2016-2021)
  • 7.1.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021)
• 7.2 Europe Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type
  • 7.2.1 Europe Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
• 7.3 Europe Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application
  • 7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)

8 China Peripheral Intervention Drug-Eluting Devices Market Facts & Figures

• 8.1 China Peripheral Intervention Drug-Eluting Devices Sales by Company
  • 8.1.1 China Peripheral Intervention Drug-Eluting Devices Sales by Company (2016-2021)
  • 8.1.2 China Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021)
• 8.2 China Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type
  • 8.2.1 China Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
• 8.3 China Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application
  • 8.3.1 China 244 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Peripheral Intervention Drug-Eluting Devices Market Facts & Figures

• 9.1 Japan Peripheral Intervention Drug-Eluting Devices Sales by Company
  • 9.1.1 Japan Peripheral Intervention Drug-Eluting Devices Sales by Company (2016-2021)
  • 9.1.2 Japan Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021)
• 9.2 Japan Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type
  • 9.2.1 Japan Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
• 9.3 Japan Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Peripheral Intervention Drug-Eluting Devices Market Facts & Figures

• 10.1 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales by Company
  • 10.1.1 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021)
• 10.2 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type
  • 10.2.1 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Peripheral Intervention Drug-Eluting Devices Market Facts & Figures

• 11.1 India Peripheral Intervention Drug-Eluting Devices Sales by Company
  • 11.1.1 India Peripheral Intervention Drug-Eluting Devices Sales by Company (2016-2021)
  • 11.1.2 India Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021)
• 11.2 India Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type
  • 11.2.1 India Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
• 11.3 India Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application
  • 11.3.1 India Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Peripheral Intervention Drug-Eluting Devices Business

• 12.1 Medtronic plc
  • 12.1.1 Medtronic plc Corporation Information
  • 12.1.2 Medtronic plc Business Overview
  • 12.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Products Offered
  • 12.1.5 Medtronic plc Recent Development
• 12.2 Boston Scientific Corporation
  • 12.2.1 Boston Scientific Corporation Corporation Information
  • 12.2.2 Boston Scientific Corporation Business Overview
  • 12.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
  • 12.2.5 Boston Scientific Corporation Recent Development
• 12.3 Abbott Laboratories
  • 12.3.1 Abbott Laboratories Corporation Information
  • 12.3.2 Abbott Laboratories Business Overview
  • 12.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Products Offered
  • 12.3.5 Abbott Laboratories Recent Development
• 12.4 Cardinal Health
  • 12.4.1 Cardinal Health Corporation Information
  • 12.4.2 Cardinal Health Business Overview
  • 12.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Products Offered
  • 12.4.5 Cardinal Health Recent Development
• 12.5 B. Braun Melsungen AG
  • 12.5.1 B. Braun Melsungen AG Corporation Information
  • 12.5.2 B. Braun Melsungen AG Business Overview
  • 12.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Products Offered
  • 12.5.5 B. Braun Melsungen AG Recent Development
• 12.6 Biosensors International Group Ltd.
  • 12.6.1 Biosensors International Group Ltd. Corporation Information
  • 12.6.2 Biosensors International Group Ltd. Business Overview
  • 12.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Products Offered
  • 12.6.5 Biosensors International Group Ltd. Recent Development
• 12.7 C.R. Bard, Inc.
  • 12.7.1 C.R. Bard, Inc. Corporation Information
  • 12.7.2 C.R. Bard, Inc. Business Overview
  • 12.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Products Offered
  • 12.7.5 C.R. Bard, Inc. Recent Development
• 12.8 Abbott
  • 12.8.1 Abbott Corporation Information
  • 12.8.2 Abbott Business Overview
  • 12.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Products Offered
  • 12.8.5 Abbott Recent Development
• 12.9 The Lubrizol Corporation
  • 12.9.1 The Lubrizol Corporation Corporation Information
  • 12.9.2 The Lubrizol Corporation Business Overview
  • 12.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
  • 12.9.5 The Lubrizol Corporation Recent Development
• 12.10 Terumo Corporation
  • 12.10.1 Terumo Corporation Corporation Information
  • 12.10.2 Terumo Corporation Business Overview
  • 12.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
  • 12.10.5 Terumo Corporation Recent Development

13 Peripheral Intervention Drug-Eluting Devices Manufacturing Cost Analysis

• 13.1 Peripheral Intervention Drug-Eluting Devices Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
• 13.4 Peripheral Intervention Drug-Eluting Devices Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Peripheral Intervention Drug-Eluting Devices Distributors List
• 14.3 Peripheral Intervention Drug-Eluting Devices Customers

15 Market Dynamics

• 15.1 Peripheral Intervention Drug-Eluting Devices Market Trends
• 15.2 Peripheral Intervention Drug-Eluting Devices Drivers
• 15.3 Peripheral Intervention Drug-Eluting Devices Market Challenges
• 15.4 Peripheral Intervention Drug-Eluting Devices Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List